CLINICAL_TRIALS ClinicalTrials.gov record update

A Multicenter Study With a Randomized, Double-Blind, Placebo-Controlled Period, Followed by an Open-Label Maintenance Dosing Period to Evaluate the Efficacy and Safety of Secukinumab in Patients With Ichthyoses

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03041038
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:31.995628+00:00
Published At: 2021-08-25T00:00:00+00:00
Record Updated At: 2021-08-25
Results Posted At: 2021-08-25
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Ichthyosis", "Autosomal Recessive Congenital Ichthyosis", "Lamellar Ichthyosis", "Congenital Ichthyosiform Erythroderma", "Epidermolytic Ichthyosis", "Netherton Syndrome"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-08-25"
protocolSection.identificationModule.nctId: "NCT03041038"
protocolSection.identificationModule.officialTitle: "A Multicenter Study With a Randomized, Double-Blind, Placebo-Controlled Period, Followed by an Open-Label Maintenance Dosing Period to Evaluate the Efficacy and Safety of Secukinumab in Patients With Ichthyoses"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2021-08-25"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.